D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.23% |
| 2 | Consumer Discretionary | 11.75% |
| 3 | Healthcare | 9.92% |
| 4 | Financials | 7.86% |
| 5 | Industrials | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
VF Corp
VFC
$5.92B
| $12.2M | 0.01% |
122,500
-116,766
| -49% | -$10.5M |
|
1052
Microchip Technology
MCHP
$38.8B
| $12.2M | 0.01% |
233,058
-582,882
| -71% | -$28.2M |
|
1053
Agios Pharmaceuticals
AGIO
$2.08B
| $12.2M | 0.01% |
254,674
+237,759
| +1,406% | +$8.99M |
|
1054
Bloomin' Brands
BLMN
$754M
| $12.1M | 0.01% |
550,143
-130,159
| -19% | -$2.76M |
|
1055
Assured Guaranty
AGO
$3.73B
| $12.1M | 0.01% |
247,109
+119,351
| +93% | +$5.71M |
|
1056
Atkore
ATKR
$2.41B
| $12.1M | 0.01% |
298,574
+49,892
| +20% | +$1.85M |
|
1057
PUT
DuPont de Nemours
DD
$18.6B
| $12.1M | 0.01% |
149,756
+39,515
| +36% | +$3.28M |
|
|
AMAG
1058
DELISTED
AMAG Pharmaceuticals
AMAG
| $12.1M | 0.01% |
990,553
-5,500
| -0.6% | -$60.1K |
|
1059
CALL
EOG Resources
EOG
$77.7B
| $12M | 0.01% |
143,700
+16,200
| +13% | +$1.19M |
|
1060
CALL
Essex Property Trust
ESS
$19.1B
| $12M | 0.01% |
40,000
-2,200
| -5% | -$695K |
|
|
JCP
1061
DELISTED
J.C. Penney Company, Inc.
JCP
| $12M | 0.01% |
10,726,562
+2,122,317
| +25% | +$2.25M |
|
1062
iHeartMedia
IHRT
$531M
| $12M | 0.01% |
710,043
| – | – |
|
1063
CALL
Twilio
TWLO
$28.6B
| $12M | 0.01% |
122,100
+8,600
| +8% | +$878K |
|
1064
Zions Bancorporation
ZION
$10.1B
| $12M | 0.01% |
+230,781
| New | +$11.2M |
|
1065
Cameco
CCJ
$36.8B
| $12M | 0.01% |
1,344,494
+655,755
| +95% | +$6.06M |
|
1066
PUT
Bath & Body Works
BBWI
$3.97B
| $12M | 0.01% |
816,544
+228,969
| +39% | +$3.31M |
|
1067
PUT
Ulta Beauty
ULTA
$21.8B
| $11.9M | 0.01% |
47,000
-2,400
| -5% | -$586K |
|
1068
MDU Resources
MDU
$4.18B
| $11.8M | 0.01% |
1,048,046
-71,059
| -6% | -$776K |
|
1069
Fossil Group
FOSL
$260M
| $11.8M | 0.01% |
1,499,511
-62,836
| -4% | -$580K |
|
1070
CALL
Occidental Petroleum
OXY
$55.7B
| $11.8M | 0.01% |
285,575
+8,800
| +3% | +$353K |
|
1071
Haemonetics
HAE
$3.88B
| $11.8M | 0.01% |
102,374
+74,825
| +272% | +$9.05M |
|
|
TPH
1072
DELISTED
Tri Pointe Homes
TPH
| $11.7M | 0.01% |
752,849
+258,522
| +52% | +$3.98M |
|
|
IMMU
1073
DELISTED
Immunomedics Inc
IMMU
| $11.7M | 0.01% |
553,638
+408,034
| +280% | +$7.2M |
|
|
ATVI
1074
PUT
DELISTED
Activision Blizzard
ATVI
| $11.7M | 0.01% |
197,100
-9,800
| -5% | -$543K |
|
1075
CALL
Edwards Lifesciences
EW
$49.4B
| $11.7M | 0.01% |
150,600
+10,800
| +8% | +$843K |
|
Similar funds
D.E. Shaw & Co's Q4 2019 Portfolio in Review
As of Q4 2019, D.E. Shaw & Co held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
D.E. Shaw & Co's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- D.E. Shaw & Co added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- D.E. Shaw & Co's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- D.E. Shaw & Co fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- D.E. Shaw & Co's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- D.E. Shaw & Co opened 572 new positions and closed 412 in Q4 2019.
- D.E. Shaw & Co's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.